Screener
SELLAS Life Sciences Group, Inc. SLS EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001390478-26-000008
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Loss from operations | (9,252) | (6,063) |
| Non-operating income: | ||
| Interest income | 845 | 250 |
| Total non-operating income | 845 | 250 |
| Net loss | $(8,407) | $(5,813) |
| Per share information: | ||
| Net loss per common share, basic and diluted | $(0.05) | $(0.07) |
| Weighted-average common shares outstanding, basic and diluted | 172,481,541 | 87,760,320 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is SELLAS Life Sciences Group, Inc.'s EPS (basic)?
- SELLAS Life Sciences Group, Inc. (SLS) reported EPS (basic) of -$0.05 in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s EPS (basic) changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s EPS (basic) increased by 28.6% year-over-year, from -$0.07 to -$0.05.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s EPS (basic) has grown at a -34.2% compound annual growth rate (CAGR), from -$1.33 to -$0.25.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about SELLAS Life Sciences Group, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude